...
首页> 外文期刊>The American Journal of Cardiology >Effect of Preinfarction Angina Pectoris on Long-term Survival in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention
【24h】

Effect of Preinfarction Angina Pectoris on Long-term Survival in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention

机译:原发性经皮冠状动脉介入治疗ST段抬高型心肌梗死患者梗死前心绞痛对长期生存的影响

获取原文
获取原文并翻译 | 示例
           

摘要

The influence of preinfarction angina pectoris (AP) on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI) remains controversial. In 5,429 patients with acute myocardial infarction (AMI) enrolled in the Coronary Revascularization Demonstrating Outcome Study in Kyoto AMI Registry, the present study population consisted of 3,476 patients with STEMI who underwent primary PCI within 24 hours of symptom onset and in whom the data on preinfarction AP were available. Preinfarction AP defined as AP occurring within 48 hours of hospital arrival was present in 675 patients (19.4%). Patients with preinfarction AP was younger and more often had anterior AMI and longer total ischemic time, whereas they less often had history of heart failure, atrial fibrillation, and shock presentation. The infarct size estimated by peak creatinine phosphokinase was significantly smaller in patients with than in patients without preinfarction AP (median [interquartile range] 2,141 [965 to 3,867] IU/L vs 2,462 [1,257 to 4,495] IU/L, p <0.001). The cumulative 5-year incidence of death was significantly lower in patients with preinfarction AP (12.4% vs 20.7%, p <0.001) with median follow-up interval of 1,845 days. After adjusting for confounders, preinfarction AP was independently associated with a lower risk for death (hazard ratio 0.69, 95% confidence interval 0.54 to 0.86, p = 0.001). The lower risk for 5-year mortality in patients with preinfarction AP was consistently observed across subgroups stratified by total ischemic time, initial Thrombolysis In Myocardial Infarction flow grade, hemodynamic status, infarct location, and diabetes mellitus. In conclusion, preinfarction AP was independently associated with lower 5-year mortality in patients with STEMI who underwent primary PCI. (C) 2014 Elsevier Inc. All rights reserved.
机译:接受原发性经皮冠状动脉介入治疗(PCI)的ST段抬高型心肌梗死(STEMI)患者的梗塞前心绞痛(AP)对长期临床结局的影响仍存在争议。在京都AMI登记处进行的冠状动脉血运重建证明结果研究的5,429例急性心肌梗死(AMI)患者中,本研究人群包括3,476例STEMI患者,他们在症状发作后24小时内接受了原发性PCI,并且其中有梗死前数据AP可用。 675例患者中有梗死前AP定义为在到达医院后48小时内发生的AP(19.4%)。梗死前AP患者较年轻,前AMI多见,总缺血时间更长,而心衰,房颤和休克表现史较少。有肌酐磷酸激酶峰值估计的梗死面积明显小于无梗塞前AP的患者(中位[四分位间距] 2,141 [965至3,867] IU / L与2,462 [1,257至4,495] IU / L,p <0.001) 。梗死前AP患者的5年累积死亡率显着降低(12.4%vs 20.7%,p <0.001),中位随访间隔为1845天。调整混杂因素后,梗死前AP与较低的死亡风险独立相关(危险比0.69,95%置信区间0.54至0.86,p = 0.001)。在按总缺血时间,心肌梗塞血流初始溶栓程度,血流动力学状况,梗死部位和糖尿病分层的亚组中,始终观察到梗塞前期AP患者5年死亡的风险较低。总之,在接受原发性PCI的STEMI患者中,梗死前AP与较低的5年死亡率独立相关。 (C)2014 Elsevier Inc.保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号